Exploration and validation of a novel reactive oxygen species–related signature for predicting the prognosis and chemotherapy response of patients with bladder cancer
We identified a PS based on 17 ROS-related genes that represented independent OS prognostic factors and 11 candidate SMDs for BLCA treatment, which may contribute to the development of effective individualized therapies for BLCA.
Authors
- Jing Jin (ORCID: https://orcid.org/0000-0001-7540-9271)
- Kaifang Wang (ORCID: https://orcid.org/0000-0003-0599-473X)
- Mengyao Li (ORCID: https://orcid.org/0000-0002-3199-9465)
- Jiajun Chen (ORCID: https://orcid.org/0000-0003-1065-9952)
- Lulu Zhang (ORCID: https://orcid.org/0000-0001-6065-3669)
- Shouhua Pan (ORCID: https://orcid.org/0000-0001-6960-8418)
- Gang Xu (ORCID: https://orcid.org/0000-0002-5738-2949)
- Ke Zhu (ORCID: https://orcid.org/0000-0003-1794-1328)
- Keyuan Zhao (ORCID: https://orcid.org/0000-0003-0455-7570)
- Peng Chao (ORCID: https://orcid.org/0000-0002-8737-4958)
- Gang Xu (ORCID: https://orcid.org/0000-0002-8642-8221)
- Yulei Li
Institutions
- University of Macau (MO)
- Shaoxing People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3389/fimmu.2024.1493528
- Citations
- 3
- Primary Topic
- Free Radicals and Antioxidants
- Type
- article
- Field-Weighted Citation Impact
- 0.75
Funders
- Medical and Health Research Project of Zhejiang Province